Home
Topics
Affordable Care Act
COVID-19
Global Health Policy
Health Costs
Health Misinformation and Trust
HIV/AIDS
Medicaid
Medicare
Mental Health
Patient and Consumer Protections
Private Insurance
Racial Equity and Health Policy
Uninsured
Women’s Health Policy
Polling
State Health Facts
State Health Facts
Custom State Reports
KFF Health News
Social Impact Media
Peterson-KFF Health System Tracker
Newsroom
Newsroom
News Releases
Events
Subscribe to Emails
Cite Us/Reprint
Media Contacts
Join Our Team
About Us
About KFF
From Drew Altman
Our People
Our Programs
KFF Board
Contact Us
Support Our Work
Conference Centers
San Francisco, CA
Washington, DC
The independent source for health policy research, polling, and news.
menu
The independent source for health policy research, polling, and news.
Donate
Follow us
Email
Open Search...
Search KFF.org
Election 2024
Abortion in the U.S.
Health Policy 101
Charts & Slides
Slides
Slideshows
Home
Charts & Slides
Among the 10 Antiretrovirals with the Highest Part D Spending in 2017, All Had List Price…
Among the 10 Antiretrovirals with the Highest Part D Spending in 2017, All Had List Price Increases Exceeding Inflation
Published:
Dec 18, 2019
Facebook
Twitter
LinkedIn
Email
Print
Download Full Power Point
Download Image
Topics
HIV/AIDS
Medicare
Health Costs
Tags
HIV/AIDS in U.S.
Medicare Part D
Prescription Drugs
Antiretrovirals
Explore Charts & Slides by Topic
Explore KFF Slides by Topic
Affordable Care Act
Coronavirus (COVID-19)
Global Health Policy
Health Costs
Health Misinformation and Trust
HIV/AIDS
Medicaid
Medicare
Mental Health
Other
Private Insurance
Racial Equity and Health Policy
Uninsured
Women's Health Policy
Search Charts & Slides For:
All charts & slides
Also of Interest
FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
What to Know About Medicare Part D Premiums
Changes to Medicare Part D in 2024 and 2025 Under the Inflation Reduction Act and How Enrollees Will Benefit